↓ Skip to main content

The REMEDEE Trial A Randomized Comparison of a Combination Sirolimus-Eluting Endothelial Progenitor Cell Capture Stent With a Paclitaxel-Eluting Stent

Overview of attention for article published in JACC: Cardiovascular Interventions, March 2013
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (84th percentile)
  • Good Attention Score compared to outputs of the same age and source (76th percentile)

Mentioned by

blogs
1 blog

Citations

dimensions_citation
96 Dimensions

Readers on

mendeley
98 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
The REMEDEE Trial A Randomized Comparison of a Combination Sirolimus-Eluting Endothelial Progenitor Cell Capture Stent With a Paclitaxel-Eluting Stent
Published in
JACC: Cardiovascular Interventions, March 2013
DOI 10.1016/j.jcin.2012.10.018
Pubmed ID
Authors

Michael Haude, Stephen W.L. Lee, Stephen G. Worthley, Sigmund Silber, Stefan Verheye, Sandra Erbs, Mohd Ali Rosli, Roberto Botelho, Ian Meredith, Kui Hian Sim, Pieter R. Stella, Huay-Cheem Tan, Robert Whitbourn, Sukumaran Thambar, Alexandre Abizaid, Tian Hai Koh, Peter Den Heijer, Helen Parise, Ecaterina Cristea, Akiko Maehara, Roxana Mehran

Abstract

This study sought to compare the efficacy and safety results after coronary implantation of a combined sirolimus-eluting CD34 antibody coated Combo stent (OrbusNeich Medical, Ft. Lauderdale, Florida) with the paclitaxel-eluting Taxus Liberté stent (PES) (Boston Scientific, Natick, Massachusetts). This report summarizes the first-in-man randomized, controlled multicenter REMEDEE trial (Randomized study to Evaluate the safety and effectiveness of an abluMinal sirolimus coatED bio-Engineered StEnt) angiographic, intravascular ultrasound, and clinical results up to 12 months.

Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 98 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Czechia 1 1%
Unknown 97 99%

Demographic breakdown

Readers by professional status Count As %
Student > Ph. D. Student 18 18%
Student > Bachelor 14 14%
Researcher 13 13%
Student > Postgraduate 10 10%
Student > Doctoral Student 9 9%
Other 14 14%
Unknown 20 20%
Readers by discipline Count As %
Medicine and Dentistry 42 43%
Biochemistry, Genetics and Molecular Biology 5 5%
Agricultural and Biological Sciences 4 4%
Computer Science 3 3%
Engineering 3 3%
Other 12 12%
Unknown 29 30%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 9. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 28 May 2013.
All research outputs
#3,798,066
of 25,371,288 outputs
Outputs from JACC: Cardiovascular Interventions
#1,686
of 4,030 outputs
Outputs of similar age
#31,062
of 210,236 outputs
Outputs of similar age from JACC: Cardiovascular Interventions
#6
of 25 outputs
Altmetric has tracked 25,371,288 research outputs across all sources so far. Compared to these this one has done well and is in the 83rd percentile: it's in the top 25% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 4,030 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 15.2. This one has gotten more attention than average, scoring higher than 57% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 210,236 tracked outputs that were published within six weeks on either side of this one in any source. This one has done well, scoring higher than 84% of its contemporaries.
We're also able to compare this research output to 25 others from the same source and published within six weeks on either side of this one. This one has done well, scoring higher than 76% of its contemporaries.